NCI Agrees To give NSABP One Year Until Competition; Advisors OK Concept
In Brief: William Blot, Michael Grever, Others To Leave NCI; RAC Approves Naked DNA Vaccine Trial
DCT Board Restores Funding to Rosenberg’s Lymphocyte Projects
Univ. Of Pittsburgh Seeks Senior Prevention Trial Of Tamoxifin should Resume
House Subcommittee allocates $11.3 Billion To NIH, $2.1 Bil. To NCI
NCI Audit Finds “Low Quality” Research At Calif. Foundation
DCE Board Approves Study of Breast Cancer On Long Island
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Cancer patients with Medicare Advantage have access to fewer providers than Medicare patients, cross-sectional study finds
- A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m. - Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- A new diagnostic lens—and a lasting scientific legacy
- OMB’s plan to increase political control of science faces stiff opposition on Capitol Hill









